Immune-related (IR)-pneumonitis during the COVID-19 pandemic: multidisciplinary recommendations for diagnosis and management

by Joshua E Reuss, Seema Mehta Steinke, Clare Rock
Published 2020-06-01

Oral Chemotherapy for Treatment of Lung Cancer

by Sushma Jonna, Joshua E. Reuss, Chul Kim, Stephen V. Liu
Published 2020-04-01

EML4-ALK Rearrangement as a Mechanism of Resistance to Osimertinib in Metastatic Lung Adenocarcinoma: A Case Report

by Xinyu von Buttlar, MD, MS, Joshua E. Reuss, MD, Stephen V. Liu, MD, Chul Kim, MD, MPH
Published 2021-06-01

Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer

by David Jones, Taha Merghoub, Hok Yee Chan, Franco Verde, Daphne Wang, James R White, Tricia R Cottrell, Joshua E Reuss, Stephen Broderick, Kellie N Smith, Marianna Zahurak, Mara Lanis, Joseph C Murray, Caroline McCarthy, Stephen Yang, Richard Battafarano, Errol Bush, Malcolm Brock, Jinny Ha, Janis Taube, Peter Illei, Ben Levy, Jamie E Chaft
Published 2020-07-01

Pretreatment Lung Function and Checkpoint Inhibitor Pneumonitis in NSCLC

by Joshua E. Reuss, MD, Emily Brigham, MD, MHS, Kevin J. Psoter, PhD, Khinh Ranh Voong, MD, Bairavi Shankar, BS, David S. Ettinger, MD, Kristen A. Marrone, MD, Christine L. Hann, MD, Benjamin Levy, MD, Josephine L. Feliciano, MD, Julie R. Brahmer, MD, David Feller-Kopman, MD, Andrew D. Lerner, MD, Hans Lee, MD, Lonny Yarmus, DO, Russell K. Hales, MD, Franco D’Alessio, MD, Sonye K. Danoff, MD, PhD, Patrick M. Forde, MBBCH, Karthik Suresh, MD, Jarushka Naidoo, MBBCH, MHS
Published 2021-10-01